Covered recipient · General Payments record
NINA V LOGVINENKO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$6,295.48
- Reported across 202 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $980.35 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $409.31 | 6 |
| ABBVIE INC. | $313.37 | 18 |
| GlaxoSmithKline, LLC. | $137.37 | 2 |
| Supernus Pharmaceuticals, Inc. | $120.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.54 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896503 | CMS |
| ABBVIE INC. | $120.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896505 | CMS |
| ABBVIE INC. | $14.95 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896507 | CMS |
| ABBVIE INC. | $9.39 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896509 | CMS |
| ABBVIE INC. | $7.74 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896511 | CMS |
| ABBVIE INC. | $9.22 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896513 | CMS |
| ABBVIE INC. | $32.67 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896515 | CMS |
| ABBVIE INC. | $11.67 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896517 | CMS |
| ABBVIE INC. | $17.17 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896519 | CMS |
| ABBVIE INC. | $4.19 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896521 | CMS |
| ABBVIE INC. | $4.73 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896523 | CMS |
| ABBVIE INC. | $10.44 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896525 | CMS |
| ABBVIE INC. | $18.38 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896527 | CMS |
| ABBVIE INC. | $6.93 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896529 | CMS |
| ABBVIE INC. | $10.13 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896531 | CMS |
| ABBVIE INC. | $5.72 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896533 | CMS |
| ABBVIE INC. | $5.66 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896535 | CMS |
| ABBVIE INC. | $9.42 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104896537 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.44 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104766148 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.16 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105452665 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.51 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105782812 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.98 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105222491 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.37 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104211661 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.85 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105510505 | CMS |
| GlaxoSmithKline, LLC. | $14.92 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116256347 | CMS |
| GlaxoSmithKline, LLC. | $122.45 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116726346 | CMS |
| Supernus Pharmaceuticals, Inc. | $120.30 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147891838 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.